Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.24.2.u1
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash $ 7,224,875 $ 6,989,424
Acquired patents, net 3,585 5,391
Total assets 7,228,460 6,994,815
Current liabilities    
Accounts payable & accrued interest 1,335,231 256,317
Unreimbursed expenses 17,797 38,089
Total current liabilities 1,353,028 294,406
Total liabilities 1,353,028 294,406
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 13,067,687 and 12,848,165 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 13,068 12,848
Additional paid-in capital 61,306,810 57,052,130
Accumulated deficit (55,444,446) (50,364,569)
Total stockholders’ equity 5,875,432 6,700,409
Total liabilities and stockholders’ equity $ 7,228,460 $ 6,994,815